Modern Clinical Medicine Research

Download PDF (335.8 KB) PP. 38 - 44 Pub. Date: October 1, 2018

DOI: 10.22606/mcmr.2018.24002

• Ieong Chon Man^*
  Department of radiology, Conde de São Januário Hospital, Macao, China
• Liang Gang Zhu
  Department of vascular surgery, Conde de São Januário Hospital, Macao, China
• Tam Man Pan
  Department of radiology, Conde de São Januário Hospital, Macao, China
• Kong Soi Chau
  Department of radiology, Conde de São Januário Hospital, Macao, China
• Kuok Cheong U
  Department of radiology, Conde de São Januário Hospital, Macao, China

Objective: To investigate the feasibility and clinical efficacy of stent implantation and balloon angioplasty in the treatment of severe lower extremity arterial ischemia. Methods: Twenty- two patients with severe lower extremity ischemia were enrolled from January 2016 to December 2016. According to the scope of the patient's lesions, we choose the appropriate length of the balloon, according to different degrees of balloon dilation lesion stenosis or occlusion of the adjacent multiple short part of the lesion, as far as possible the formation of long balloon. Metallic stents were implanted in the dilated vessels to prevent restenosis. The incidence of postoperative complications, the rate of technical success and the clinical efficacy were observed, and the primary patency rate was evaluated through follow-up. Results: The total of 22 patients had 42 vessels with varying degrees of stenosis and occlusion, with an operative success rate of 100%. The primary patency rate was 90.9% and 81.8% at 6 and 12 months respectively. The ankle brachial index was significantly higher than that before the operation, and the Rutherford classification of most patients was significantly improved after the operation (P<0.05). No serious complications or death cases were found in this study. The average postoperative hospital stay was 4.3 days. Conclusion: For the severe ischemic disease of the lower extremities, interventional therapy is more effective than surgical treatment, with fewer complications and faster recovery. Stent implantation combined with balloon therapy does not affect the postoperative blood supply of the affected limb. The initial technical and clinical success rate is very high. It is a safe and effective method for the treatment of severe arterial ischemia disease of the lower extremities.

Peripheral arterial occlusive disease, stent implantation, balloon dilatation, treatment

[1] Sigala F, Menenakos CH, Sigalas P, et al. Transluminal angioplasty of isolated crual aterial lesions in diabetics with critical limb ischemia. Vasa, 2005, 34:186-191.

[2] Lonn L, Delle M, Karlstrom L, et al. Should blunt arterial trauma to the extremities be treated with endovascular techniques. J Trauma, 2005, 59:1224-1227.

[3] Tsujimura, Takuya, et al. Two-year Clinical Outcomes Post Implantation of EpicTM Self-Expanding Nitinol Stents for the Aortoiliac Occlusive Disease in Patients with Peripheral Arterial Disease. Journal of atherosclerosis and thrombosis (2017): 41152.

[4] Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 388(10053): 1545–1602.

[5] Finlayson EV, Birkmeyer JD. Operative mortality with elective surgery in older adults[J]. Eff Clin Pract, 2001, 4:172-177.

[6] Baerlocher, Mark Otto, et al. Meta-analysis of drug-eluting balloon angioplasty and drug-eluting stent placement for infrainguinal peripheral arterial disease. Journal of Vascular and Interventional Radiology 26.4 (2015): 459-473.

[7] Bosch JL, Hunink MG: Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology, 1997; 204: 87-96.

[8] George, Jon C. CRT-300.18 Supera Stent Outcomes In Above-The-Knee Interventions: Effects Of Compression And Elongation (Sake-Compel) Sub-Study. JACC: Cardiovascular Interventions10.3 Supplement (2017): S43.

[9] Ichihashi, Shigeo, et al. In Vitro Quantification of Luminal Denudation After Crimping and Balloon Dilatation of Endothelialized Covered Stents. CardioVascular and Interventional Radiology (2017): 1-8.

[10] de Boer, Sanne W., et al. Short-term Results of the RAPID Ra ndomized Trial of the Legflow P aclitaxel-Eluting Balloon With Supera Stenting vs Supera Stenting Alone for the Treatment of I nterme d iate and Long Superficial Femoral Artery Lesions. Journal of Endovascular Therapy(2017): 1526602817725062.

[11] Schneider, Peter A. Evolution and current use of technology for superficial femoral and popliteal artery interventions for claudication. Journal of Vascular Surgery 66.3 (2017): 916-923.

[12] Ohki, Takao, et al. Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions. Journal of Vascular Surgery(2017).

[13] Reijnen, Michel MPJ, et al. 1-Year Results of a Multicenter Randomized Controlled Trial Comparing Heparin- Bonded Endoluminal to Femoropopliteal Bypass. JACC: Cardiovascular Interventions 10.22 (2017): 2320-2331.

[14] Klein, Andrew J., and Charles B. Ross. Endovascular treatment of lower extremity peripheral arterial disease. Trends in cardiovascular medicine 26.6 (2016): 495-512.

[15] Fujihara, Masahiko, et al. Angiographic Dissection Patterns and Patency Outcomes After Balloon Angioplasty for Superficial Femoral Artery Disease. Journal of Endovascular Therapy (2017): 1526602817698634.

[16] Faglia E, Clerici G, Losa S, et a1. Limb revascularization feasibility in diabetic patients with critical limb ischemia: Results from a cohoa of 344 consecutive unselected diabetic patients evaluated in 2009[J]. Diabetes Res Clin Pract. 2012, 95(3): 364—371.

[17] Faaglia E, Clerici G, Clerissi J, et a1. Long—term prognosis of diabetic patients with critical limb iscbemia: a population—based cohen study[J]. Diabetes Care, 2009, 32(5): 822-827.